Patient Basic Information Patient: Mr. Charles Walker) Nationality: Yemen Disease Diagnosis: Liver Cancer Clinical Hospital: University of Hong Kong Shenzhen Hospital Treatment: Targeted to Treatment + Immunotherapy Accommodation: 25 days Treatment Costs: About 1256664 yuan Treatment Effect: Healing Description: Mr. Charles is from Yemen and was diagnosed with liver cancer locally.
After arriving at the Shenzhen Hospital of the University of Hong Kong, the International Medical Services team arranged for the first time multidisciplinary MDT for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided full translation, accompaniment and landing services. During the treatment process, the team of experts at the Shenzhen Hospital of the University of Hong Kong used a comprehensive set of targeted therapies + immunotherapies. During the treatment, the medical team closely monitored the patient's indicators, dynamic adjustment programs.
After 25 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached the hospital standard. Treatment results The patient finally recovered. When he left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him, and continued to track recovery through the remote follow-up system.
'Mr. Liu Charles, experts have criticized this case as a typical case of cross-border suspected serious medical conditions. The University of Hong Kong Shenzhen Hospital, based on a multidisciplinary collaborative mechanism, has developed a targeted treatment+immunotherapy program for liver cancer, reflecting the comprehensive strength of Chinese hospitals in the field of suspected medical conditions and a summary of how international medical services are regulated.